AddLife

AddLife Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of AddLife (ALIF B.ST) as of Oct 8, 2026 is 34.16. In the previous year, Cash Conversion Cycle (CCC) was 90.09 — a change of -62.09% (lower).

Cash Conversion Cycle

34.16

YoY

-62.09%

Last updated:

Cash Conversion Cycle (CCC) of AddLife is 2025 34.16 . Cash Conversion Cycle (CCC) of AddLife was 2024 90.09 . It decreases by -62.09% lower compared to the previous year.

The AddLife Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2018
17.06 SEK
Jan 1, 2019
73.14 SEK
Jan 1, 2020
51.77 SEK
Jan 1, 2021
77.91 SEK
Jan 1, 2022
98.22 SEK
Jan 1, 2023
95.74 SEK
Jan 1, 2024
90.09 SEK
Jan 1, 2025
34.16 SEK
The AddLife Cash Conversion Cycle history
YEARCash Conversion CycleYoY
34.16-62.09%
90.09-5.90%
95.74-2.52%
98.22+26.06%
77.91+50.51%
51.77-29.23%
73.14+328.75%
17.06-73.23%
63.74-6.75%
68.35+255.81%
19.21-3,184.18%
-0.62—
Access this data via the Eulerpool API

AddLife Stock analysis

What does AddLife do? AddLife AB is a publicly listed company from Sweden that operates in the medical technology and healthcare industry. The company was founded in 2015 through the merger of several companies. AddLife AB is headquartered in Stockholm and currently employs over 2,000 employees in Sweden, Denmark, Finland, Norway, and Germany. The business model of AddLife AB is based on the acquisition and integration of leading technology companies in the healthcare industry. These companies are integrated into the AddLife Group and supported. Through collaboration within the group, synergies can be leveraged and competitiveness can be increased. AddLife offers its customers a wide range of products and services in various sectors. The company operates in the areas of diagnostics & life science, medical technology, and laboratory products. Diagnostics & life science includes products in the field of in vitro diagnostics, food analysis, nuclear medicine, and animal health. AddLife offers a wide range of products and services that are used in disease research and diagnostics. In the medical technology sector, AddLife AB offers products used by the medical technology industry, hospitals, and healthcare facilities. The product range includes surgical instruments, neurosurgery, orthopedics, and cardiology. AddLife is also involved in the project development of complete solutions for customers in this field. In the laboratory products sector, AddLife AB offers products and services for laboratories and research facilities. The product range includes laboratory equipment, laboratory consumables, and life science products. AddLife also offers services in the maintenance and validation of laboratory equipment. AddLife AB also has its own product brand, Labkotec, which manufactures products for fluid control and environmental and process condition monitoring. Labkotec operates internationally and offers products for various industries, such as the food and beverage industry, energy and environmental industry, steel industry, as well as the chemical and pharmaceutical industry. AddLife is known for its innovative products and solutions and works closely with customers to find individual solutions for their needs. The company sees itself as a provider of solutions and services for the medical industry and aims to improve the health and well-being of people through its products and services. AddLife is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AddLife stock

Cash Conversion Cycle (CCC) of AddLife is 34.16 in 2025.

Cash Conversion Cycle (CCC) of AddLife changed from 90.09 to 34.16, representing a -62.09% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) AddLife since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s AddLife with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

Profitability — AddLife

All Key Metrics — AddLife